본문으로 건너뛰기
← 뒤로

Safety and Efficacy of Transoral Endoscopic Thyroidectomy Vestibular Approach Versus Conventional Open Thyroidectomy: A Systematic Review and Meta-analysis.

Surgical laparoscopy, endoscopy & percutaneous techniques 2023 Vol.33(5) p. 547-555

Huo J, Ou D, Guo Y, Chen C, Qu R, Zhao L

📝 환자 설명용 한 줄

[OBJECTIVE] To evaluate the safety and efficacy of the transoral endoscopic thyroidectomy vestibular approach (TOETVA) versus conventional open thyroidectomy (COT) for some thyroid diseases.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P < 0.0001
  • p-value P = 0.001
  • 95% CI 49.34 to 97.94
  • 연구 설계 meta-analysis

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Huo J, Ou D, et al. (2023). Safety and Efficacy of Transoral Endoscopic Thyroidectomy Vestibular Approach Versus Conventional Open Thyroidectomy: A Systematic Review and Meta-analysis.. Surgical laparoscopy, endoscopy & percutaneous techniques, 33(5), 547-555. https://doi.org/10.1097/SLE.0000000000001197
MLA Huo J, et al.. "Safety and Efficacy of Transoral Endoscopic Thyroidectomy Vestibular Approach Versus Conventional Open Thyroidectomy: A Systematic Review and Meta-analysis.." Surgical laparoscopy, endoscopy & percutaneous techniques, vol. 33, no. 5, 2023, pp. 547-555.
PMID 37523575

Abstract

[OBJECTIVE] To evaluate the safety and efficacy of the transoral endoscopic thyroidectomy vestibular approach (TOETVA) versus conventional open thyroidectomy (COT) for some thyroid diseases.

[MATERIALS AND METHODS] Databases PubMed, Embase, and Web of Science were searched. Full-text English papers that described TOETVA and COT for people with thyroid diseases were included. Randomized, nonrandomized, controlled, and uncontrolled trials were all included. Extracted data included population characteristics and intraoperative and postoperative complications.

[RESULTS] A total of 2 randomized controlled trials and 10 retrospective studies, including 3048 patients, were included in the meta-analysis. Meta-analysis results suggested that the intraoperative conditions and postoperative complication rates did not differ significantly between the two groups. However, in the TOETVA group, there is a slightly longer operative time [weighted mean difference (WMD): 73.64; 95% CI: 49.34 to 97.94; P < 0.0001], drainage (WMD: 91.0; 95% CI: 35.52 to 146.48; P = 0.001), and hospital stay (WMD: 0.28; 95% CI: 0.18 to 0.38; P < 0.0001).

[CONCLUSION] For most of the benign thyroid nodules and selected patients with papillary thyroid cancer, TOETVA seems to be as feasible and safe as COT.

MeSH Terms

Humans; Thyroidectomy; Natural Orifice Endoscopic Surgery; Operative Time; Postoperative Complications; Length of Stay; Treatment Outcome; Thyroid Diseases; Mouth

같은 제1저자의 인용 많은 논문 (4)